Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03866616 · ClinicalTrials.gov registry record · NA
Evaluation Study of the Impact of the New Brain Builders Parenting Class
A NA study, sponsored by William Marsh Rice University.
- Terminated
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT03866616: Clinical Trial NA study, sponsored by William Marsh Rice University.
NCT03866616 is a NA study that was terminated before completion, run by William Marsh Rice University. The registered enrollment target is 145 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03866616, a NA study, was terminated before completion, sponsored by William Marsh Rice University.
- TERMINATED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
The objective of this research is to evaluate the effectiveness of the parenting program on increasing positive parent-child interactions and increasing cognitive achievement in children. Overall, this project is intended to benefit women and children and supplement WIC services. The Brain Builders Parenting Class Evaluation Study Research Questions include the following: 1. Does the program impact child development outcomes such as kindergarten readiness? 2. Does the program increase parental knowledge about the importance of high-quality parent-child interaction for child development? 3. Does the program impact the quality and quantity of the parent-child interactions?
Primary Outcome
The child development will be assessed by using the Caregiver Reported Early Development Index (CREDI). The CREDI measures five dimension of child development: Motor development, Language development; Socioemotional development; Cognitive development; and Mental health. The CREDI was designed to serve as a population-level measure of early childhood development for children from birth to age three. As the name suggests, the CREDI exclusively relies on caregiver reports, and thus primarily focuse
Interventions
- BEHAVIORAL Brain Builders Parenting Class
- BEHAVIORAL Control (Usual care)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2019-12-15 |
| Phase | NA |
Why NCT03866616 stopped before completion
NCT03866616 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Brain Builders Parenting Class is the first listed.
NCT03866616 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03866616 about?
NCT03866616 is a clinical study titled "Evaluation Study of the Impact of the New Brain Builders Parenting Class". The objective of this research is to evaluate the effectiveness of the parenting program on increasing positive parent-child interactions and increasing cognitive achievement in children. Overall, this project is intended to benefit women and children and supplement WIC services. The Brain Builders...
What is the current status of trial NCT03866616?
This trial is currently terminated. It is a NA study. The enrollment target is 145 participants. The study started on 2019-06-24. Estimated completion is 2019-12-15.
What interventions are being tested in trial NCT03866616?
The interventions under investigation include: Brain Builders Parenting Class (BEHAVIORAL), Control (Usual care) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03866616?
This trial is sponsored by William Marsh Rice University, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03866616's enrollment target sits among peer trials
145 705th of 2000 higher than 1,295 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI